BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34424336)

  • 21. Analysis of uveal melanomas and paired constitutional DNA for exclusion of a BAP1-tumor predisposition syndrome.
    Abbassi YA; Le Guin C; Bornfeld N; Bechrakis NE; Zeschnigk M; Lohmann DR
    Fam Cancer; 2023 Apr; 22(2):193-202. PubMed ID: 35920959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lower Levels of Adiponectin and Its Receptor Adipor1 in the Uveal Melanomas With Monosomy-3.
    Tura A; Thieme C; Brosig A; Merz H; Ranjbar M; Vardanyan S; Zuo H; Maassen T; Kakkassery V; Grisanti S
    Invest Ophthalmol Vis Sci; 2020 May; 61(5):12. PubMed ID: 32396633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chromosome 3 is a valid marker for prognostic testing of biopsy material from uveal melanoma later treated by brachytherapy.
    Le Guin CHD; Metz KA; Lehmann N; Kreis SH; Bornfeld N; Rudolf Lohmann D; Zeschnigk M
    Biomarkers; 2019 Mar; 24(2):134-140. PubMed ID: 30265160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Cancer Genome Atlas for uveal melanoma is predictive of patient outcomes.
    Bas Z; Grant-Kels JM; Shields CL
    Clin Dermatol; 2024; 42(1):56-61. PubMed ID: 37890680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vascular Lakes in Uveal Melanoma and Their Association With Outcome.
    Jones H; Kalirai H; Taktak A; Chen K; Coupland SE
    Transl Vis Sci Technol; 2022 Mar; 11(3):32. PubMed ID: 35348598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regression of uveal melanoma after plaque radiotherapy and thermotherapy based on chromosome 3 status.
    Shields CL; Bianciotto C; Rudich D; Materin MA; Ganguly A; Shields JA
    Retina; 2008 Oct; 28(9):1289-95. PubMed ID: 18628721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genome-wide profiling is a clinically relevant and affordable prognostic test in posterior uveal melanoma.
    Cassoux N; Rodrigues MJ; Plancher C; Asselain B; Levy-Gabriel C; Lumbroso-Le Rouic L; Piperno-Neumann S; Dendale R; Sastre X; Desjardins L; Couturier J
    Br J Ophthalmol; 2014 Jun; 98(6):769-74. PubMed ID: 24169649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma.
    Robertson AG; Shih J; Yau C; Gibb EA; Oba J; Mungall KL; Hess JM; Uzunangelov V; Walter V; Danilova L; Lichtenberg TM; Kucherlapati M; Kimes PK; Tang M; Penson A; Babur O; Akbani R; Bristow CA; Hoadley KA; Iype L; Chang MT; ; Cherniack AD; Benz C; Mills GB; Verhaak RGW; Griewank KG; Felau I; Zenklusen JC; Gershenwald JE; Schoenfield L; Lazar AJ; Abdel-Rahman MH; Roman-Roman S; Stern MH; Cebulla CM; Williams MD; Jager MJ; Coupland SE; Esmaeli B; Kandoth C; Woodman SE
    Cancer Cell; 2017 Aug; 32(2):204-220.e15. PubMed ID: 28810145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-Resolution Array CGH Analysis Identifies Regional Deletions and Amplifications of Chromosome 8 in Uveal Melanoma.
    Hammond DW; Al-Shammari NS; Danson S; Jacques R; Rennie IG; Sisley K
    Invest Ophthalmol Vis Sci; 2015 Jun; 56(6):3460-6. PubMed ID: 26030101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional characterization of 5p15.33 risk locus in uveal melanoma reveals rs452384 as a functional variant and NKX2.4 as an allele-specific interactor.
    Derrien AC; Houy A; Ganier O; Dingli F; Ningarhari M; Mobuchon L; Espejo Díaz MI; Loew D; Cassoux N; Cussenot O; Cancel-Tassin G; Margueron R; Noirel J; Zucman-Rossi J; Rodrigues M; Stern MH
    Am J Hum Genet; 2022 Dec; 109(12):2196-2209. PubMed ID: 36459980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Worldwide Incidence of Ocular Melanoma and Correlation With Pigmentation-Related Risk Factors.
    Wu M; Yavuzyigitoglu S; Brosens E; Ramdas WD; Kiliç E;
    Invest Ophthalmol Vis Sci; 2023 Oct; 64(13):45. PubMed ID: 37902747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monosomy 3 status of uveal melanoma metastases is associated with rapidly progressive tumors and short survival.
    Abdel-Rahman MH; Cebulla CM; Verma V; Christopher BN; Carson WE; Olencki T; Davidorf FH
    Exp Eye Res; 2012 Jul; 100():26-31. PubMed ID: 22569040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single nucleotide polymorphism array analysis of uveal melanomas reveals that amplification of CNKSR3 is correlated with improved patient survival.
    Lake SL; Damato BE; Kalirai H; Dodson AR; Taktak AF; Lloyd BH; Coupland SE
    Am J Pathol; 2013 Mar; 182(3):678-87. PubMed ID: 23357503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Prognostic Value of AJCC Staging in Uveal Melanoma Is Enhanced by Adding Chromosome 3 and 8q Status.
    Dogrusöz M; Bagger M; van Duinen SG; Kroes WG; Ruivenkamp CA; Böhringer S; Andersen KK; Luyten GP; Kiilgaard JF; Jager MJ
    Invest Ophthalmol Vis Sci; 2017 Feb; 58(2):833-842. PubMed ID: 28159971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Small High-Risk Uveal Melanomas Have a Lower Mortality Rate.
    Hussain RN; Coupland SE; Kalirai H; Taktak AFG; Eleuteri A; Damato BE; Groenewald C; Heimann H
    Cancers (Basel); 2021 May; 13(9):. PubMed ID: 34066842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genomic profiling and identification of high-risk uveal melanoma by array CGH analysis of primary tumors and liver metastases.
    Trolet J; Hupé P; Huon I; Lebigot I; Decraene C; Delattre O; Sastre-Garau X; Saule S; Thiéry JP; Plancher C; Asselain B; Desjardins L; Mariani P; Piperno-Neumann S; Barillot E; Couturier J
    Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2572-80. PubMed ID: 19151381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BAP1 Loss Is Associated with DNA Methylomic Repatterning in Highly Aggressive Class 2 Uveal Melanomas.
    Field MG; Kuznetsov JN; Bussies PL; Cai LZ; Alawa KA; Decatur CL; Kurtenbach S; Harbour JW
    Clin Cancer Res; 2019 Sep; 25(18):5663-5673. PubMed ID: 31285370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aggressive uveal melanoma displays a high degree of centrosome amplification, opening the door to therapeutic intervention.
    Sabat-Pośpiech D; Fabian-Kolpanowicz K; Kalirai H; Kipling N; Coupland SE; Coulson JM; Fielding AB
    J Pathol Clin Res; 2022 Jul; 8(4):383-394. PubMed ID: 35474453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of Partial Chromosome 3 Deletion in Uveal Melanomas With Metastasis-Free Survival.
    Rodrigues M; Ait Rais K; Salviat F; Algret N; Simaga F; Barnhill R; Gardrat S; Servois V; Mariani P; Piperno-Neumann S; Roman-Roman S; Delattre O; Cassoux N; Savignoni A; Stern MH; Pierron G
    JAMA Ophthalmol; 2020 Feb; 138(2):182-188. PubMed ID: 31895446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patterns of BAP1 protein expression provide insights into prognostic significance and the biology of uveal melanoma.
    Farquhar N; Thornton S; Coupland SE; Coulson JM; Sacco JJ; Krishna Y; Heimann H; Taktak A; Cebulla CM; Abdel-Rahman MH; Kalirai H
    J Pathol Clin Res; 2018 Jan; 4(1):26-38. PubMed ID: 29416875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.